1.
Long-term comparative outcomes of Hydrus versus iStent inject microinvasive glaucoma surgery implants combined with cataract surgery.
Tan Jeremy C K, Clement Colin, Healey Paul, Lim Ridia, White Andrew, Yuen Joshua et al.
Br J OphthalmolDec 20252 citationsObservational Study
This study found no significant difference in long-term glaucoma control between Hydrus and iStent inject combined with cataract surgery, with over 40% achieving success. Both are comparable options for patients.